Hans-Beat Gürtler
Directeur/Membre du Conseil chez The Genetics Co., Inc.
Profil
Hans-Beat Gürtler is currently the Director at The Genetics Co., Inc., Director at Kenta Biotech AG, Partner at Varuma AG, and Member-Life Sciences Commission at Basel Chamber of Commerce.
Previously, he served as the Global Chief Executive Officer at Elanco Tiergesundheit AG, Chief Executive Officer at Mahissa, Director-Supervisory Board at AC Immune SA, Non-Executive Director at Basilea Pharmaceutica AG, Director at Implenia AG, Director at ErfindungsVerwertung AG, Principal at Ciba-Geigy AG, Member-Management Board at Ganymed Pharmaceuticals AG, and Member-Management Board at NovImmune SA.
Postes actifs de Hans-Beat Gürtler
| Sociétés | Poste | Début |
|---|---|---|
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Directeur/Membre du Conseil | - |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Directeur/Membre du Conseil | - |
| Varuma AG | Corporate Officer/Principal | - |
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Corporate Officer/Principal | - |
Anciens postes connus de Hans-Beat Gürtler
| Sociétés | Poste | Fin |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Directeur/Membre du Conseil | 21/04/2016 |
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Directeur Général | 01/01/2002 |
ErfindungsVerwertung AG
 ErfindungsVerwertung AG Miscellaneous Commercial ServicesCommercial Services ErfindungsVerwertung AG engages in the provision of seed capital as well as consulting and market research services to startup companies in the field of life sciences. It offers project and business plan reviews, financial planning, business set-up, coaching, and assistance to find venture capital. The firm supports life sciences researchers, initiators of university projects, developers, and inventors in the field of drug development, medical technology, diagnostics, biomedicine, and nanotechnology. The company was founded in 1996 and is headquartered in Basel, Switzerland. | Directeur/Membre du Conseil | - |
| IMPLENIA AG | Directeur/Membre du Conseil | - |
| Mahissa | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AC IMMUNE SA | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| IMPLENIA AG | Industrial Services |
| Entreprise privées | 10 |
|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Health Services |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |
| Mahissa | |
| Varuma AG | |
ErfindungsVerwertung AG
ErfindungsVerwertung AG Miscellaneous Commercial ServicesCommercial Services ErfindungsVerwertung AG engages in the provision of seed capital as well as consulting and market research services to startup companies in the field of life sciences. It offers project and business plan reviews, financial planning, business set-up, coaching, and assistance to find venture capital. The firm supports life sciences researchers, initiators of university projects, developers, and inventors in the field of drug development, medical technology, diagnostics, biomedicine, and nanotechnology. The company was founded in 1996 and is headquartered in Basel, Switzerland. | Commercial Services |
Basel Chamber of Commerce
Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Commercial Services |
